Back to School: How biopharma can reboot drug development. Access exclusive analysis here

LeukoScan monoclonal antibody fragment labeled with technetium-99m data

IMMU reported Phase III data from one of the 14 sites participating,

Read the full 126 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE